Simplifying Global Compliance
FDAnews Device Daily Bulletin
J&J Mulls Diagnostic Unit Sale, Expects Product Launches in 2013
Feb. 4, 2013
Disappointing fourth quarter diagnostic sales and strong competition from companies like Abbott, Roche and Siemens have Johnson & Johnson eyeing a future without its $2.2 billion Ortho Clinical Diagnostics (OCD) business.
Devices & Diagnostics Letter
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing